3D printing giant inks deal for plant-based breast implants
Stratasys signs agreement with regenerative and aesthetic medicine company CollPlant to develop plant-based human tissues and organs.
Stratasys signs agreement with regenerative and aesthetic medicine company CollPlant to develop plant-based human tissues and organs.
Heart failure, kidney disease, sleep apnea, diabetes, back pain – disruptive medical devices emerging from Israel could transform treatment for these conditions.
Israel’s Collplant inks licensing and commercialization deal with major American biotech firm to make human organs.
Nanotech pioneer Prof. Oded Shoseyov has already founded 11 companies based on his inventions. Now he’s on his next: a 4D printing platform to create customized meals.
ISRAEL21c scouts out the most exciting advances on display at NanoIsrael 2014 in Tel Aviv, an event that drew thousands from 30 countries.